Basic HTML Version
60
VOLUME 9 NUMBER 2 • JUNE 2012
RESEARCH ARTICLE
SA JOURNAL OF DIABETES & VASCULAR DISEASE
Longo-Mbenza B. Diabetes mellitus and cardiovascular disease.
8.
Trop Cardiol
1995;
21
: 44–46.
Yki Jarvinen H. Management of type 2 diabetes and cardiovascular risk: lessons
9.
from intervention trials.
Drugs
2000;
60
: 975–983.
Treatment options for type 2 diabetes.
10.
Am Fam Phys Monog
2000;
1
: 16–19.
Kannel WB. Coronary risk factors: an overview. In: Willerson JT, Cohn JN, (eds).
11.
Cardiovascular Medical
. New York: Churchhill Livingstone, 1995: 1809–1828.
Elliot WJ, Black HR. Hypertension. In: ND Wong, HR Black, JM Gardin (eds).
12.
Preventive Cardiology. A Practical Approach
. 2nd edn. New York: McGraw Hill,
2005: 149–182.
El-Attat F, McFarlane SI, Sowers R. Diabetes, hypertension and cardiovascular
13.
derangements. pathophysiology and management.
Curr Hypertens Rep
2004;
6
(3):
215–23. DOI: 10.1007/S11906-004-0072-y.
American Diabetes Association. Treatment of hypertension in adults with diabetes.
14.
Diabetes Care
2003;
26
(Supp 1): 580–582.
Kannel WB. Risk stratification in hypertension: new insights from the Framingham
15.
study.
Am J Hypertens
2000;
13
: 3S–10S.
Alberti KGMM, Zimmet PZ. Definition diagnosis and classification of diabetes
16.
mellitus and its complication part II. Diagnosis and classification of diabetes mellitus.
Provisional report of a WHO Consultation.
Diabetes Med
1998;
15
: 539–643.
World Health Organization – International society of hypertension writing group.
17.
International Society of Hypertension statement on management of hypertension.
J Hum Hypertens
2008;
21
: 1983–1992.
Levitt NS, Katzerellenbagen JM, Bradshaw D, Hoffman MN, Bannici F. The
18.
prevalence and identification of risk factors for NIDDM in urban Africans in Cape
Town, South Africa.
Diabetes Care
1993;
164
: 601–607.
Dowse GK, Zimmet P. A model protocol for diabetes and other non-communicable
19.
diseases field study.
World Health Stat Q
1992;
45
: 360–372.
National Institute of Health. National Heart Lung and Blood Institute Clinical
20.
Guidelines on Identification, Evaluation and Treatment of Overweight and Obesity
in Adults. The evidence report.
Obes Res
1998;
6
: 515–595.
Friedewald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low
21.
density lipoprotein-cholesterol in plasma, without use of the preparative ultra-
centrifuge.
Clin Chem
1972;
18
; 499–502.
Araoye MA. Left ventricular hypertrophy by eletrocardiography; A code system
22.
applicable to negroes.
Nig Post Grad Med J
1996;
3
: 92–97.
Katibi IA, Adenle AD. Comparison between various criteria for the diagnosis of left
23.
ventricular hypertrophy and echocardiogram in adult hypertensive Nigerians.
Nig
Med Pract
2003;
43
: 3–6.
Omotoso ABO, Opadijo OG, Araoye MA. Diabetes mellitus and hypertension in
24.
Nigerians: A review of 572 diabetic patients.
Nig J Med
1999;
8
: 108–111.
Wicks ACB, Love RF, Jones JJ. Alcohol a cause of diabetes in Rhodesia.
25.
S Afr Med
J
1974;
48
: 1115–1117.
Talat N, Aamir K, Chaudhry MA. Dyslipidaemia in type 2 diabetes mellitus patients
26.
in a teaching hospital of Lahore, Pakistan.
Pak J Med Sci
2003;
19
: 283–286.
Tranche S, Galgo A, Xavier M,
27.
et al.
Cardiovascular risk factor in type 2 diabetic
patients: multifactorial intervention in primary care.
Kidney Int
2005;
67
: 55–62.
Wannamethae SG, Sharper AG, Perry IJ. Smoking as a metabolic risk factor for type
28.
2 diabetes in middle-aged men.
Diabetes Care
2001;
24
: 1590–1595.
Hays LM, Clark DO. Correlates of physical activity in a sample of older adults with
29.
type 2 diabetes.
Diabetes Care
1999;
22
: 706–712.
US Department of Health and Human Services. Physical activity and health: a report
30.
of the surgeon general. Atlanta, Ga: Department of Health and Human Services,
Centers for Disease Control and Prevention. National Center for Chronic Disease
Prevention and Health Promotion, 1996.
Kannel WB, Belanger A, D’Agostino R, Israel J. Physical activity and physical demand
31.
on the job and risk of cardiovascular disease and death: the Framingham study.
Am
Heart J
1986;
112
: 820–825.
Fisch A, Pichard E, Prazuck T, Leblac H, Sidibe Y, Bruckes G. Prevalence and risk
32.
factors of diabetes in rural region of Mali.
Diabetologia
1987;
30
: 859–862.
Puepet FH, Agaba EI, Chuhwak EK. Some metabolic abnormalities in type 2 diabetic
33.
patients in Jos, north central Nigeria.
Nig J Med
2003;
12
: 193–197.
NHLBI Obesity Education Initiative Expert Panel. Clinical guidelines on identification
34.
evaluation and treatment of overweight and obesity in adults: The Evidence Report.
Bethesdar, Md: National Institute of Health. National Heart, Lung and Blood
Institute, 1998.
Folsom AR, Princess RJ, Kaye SA, Munger RG. Incidence of hypertension and stroke
35.
in relation to body fat distribution and other risk factors in older women.
Stroke
1990;
21
: 701–706.
Fadupin GT, Joseph EU, Keshinro OO. Prevalence of obesity among type 2 diabetics
36.
in Nigeria; a case study of patients in Ibadan,Oyo state, Nigeria.
Afr J Med Sci
2004;
33
: 381–384.
Agboola-AbuCF, Ohwovoriole AE, Akinlade RB. The effect of glycaemic control on the
37.
prevalence and pattern of dyslipidaemia in Nigeria patients with newly diagnosed
non-insulin dependent diabetes mellitus.
W Afr J Med
2000;
19
: 27–33.
Aduba O, Onwuamaeze I, Oli J, Udeozo K. Serum cholesterol and HDL cholesterol
38.
in Nigerian diabetics.
E Afr Med J
1984;
61
: 35–39.
De Vegt F, Dekker JM, Jager A. Relation of impaired fasting and post load glucose
39.
with incidence of type 2 diabetes in Dutch population. The Hoorn Study.
J Am
Med Assoc
2001;
285
: 2109–2113.
40. Dalton M, Cameron AJ, Zimmet PZ,
40.
et al
. Waist circumference, waist hip
ratio and body mass index and their correlations with cardiovascular disease risk
factors in Australian adults.
J Int Med
2003;
254
(6): 555–563.
Isezuo SA, Badung SL, Omotoso ABO. Comparative analysis of lipid profiles
41.
among patients with type 2 diabetes mellitus, hypertension and concurrent type
2 diabetes and hypertension: a review of metabolic syndrome.
J Natl Med Assoc
2003;
95
: 328–334.
Olson DC.
42.
Risk Factor for Cardiovascular Disease: Diagnosis and Management of
Diabetes Mellitus
. 2nd edn. New York: Raven, 1988; 239–248.
Dinneen SF, Gestein HC. The association of microalbuminuria and mortality in
43.
non insulin dependent diabetes mellitus. A systematic review of literature.
Arch
Intern Med
1997;
157
: 1413–1418.
Gugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic complications.
44.
Diabetes Care
1996;
19
: 257–267.
Lyons T. Lipoprotein glycation and its metabolic consequences.
45.
Diabetes
1992;
41
(S2): 67.
Smellie WF, Sandler D, O’Donwell J, Mac Cuish AC. Screening and treatment for
46.
hyperlipidaemia in Non-insulin dependent diabetes: A prospective assessment of
350 patients.
Br J Clin Pract
1995;
49
: 83–85.
Adedeji OO, Onitiri AC. Plasma lipids in Nigerian hypertensives.
47.
Afr J Med Sci
1990;
19
: 281–284.
Obeka NC. Serum uric acid profile among hypertensive patients in Jos. Part II.
48.
Dissertation for FWACP 2005.
Jarikre AE, DimDC, Ajuluchukwu JNA. Plasma lipid levels in Nigerian hypertensives;
49.
the gender factor.
Nig Quart J Hosp Med
1996;
6
: 293–298.
Ukoh VA, Oforofuo IA. Plasma lipid profile in Nigerian normotensives, hypertensives
50.
and patients with other acquired cardiac conditions.
Nig Clin Rev
2004;
8
: 7–12.
Tuomilehto J. Plasma uric acid level and its association with diabetes mellitus and
51.
some biological parameters in a biracial population of Fiji.
Am J Epidemiol
1988;
127
(2): 321–336.
Bo S. Hypouricaemia and hyperuricaemia in type 2 diabetes: two different
52.
phenotypes.
Eur J Clin Invest
2001;
31
: 318–332.
Alebiosu CO, Odunsa BO. Metabolic syndrome in subjects with type 2 diabetes
53.
mellitus.
J Natl Med Assoc
2004;
96
: 817–821.
Adedapo KS, Abbiyesiku FM, Adedapo AA, Osotimehin BO. Microalbuminuria in
54.
controlled type 2 diabetes mellitus patients.
Afr J Med Sci
2001;
30
: 323–326.
Kolterman OG, Sackow M, Olefsky JM,
55.
et al
. Mechanisms of insulin resistance
in human obesity: Evidence for receptor and post receptor defects.
J Clin Invest
1980;
65
: 1272–1284.
Grusin H. Peculiarities of the African electrocardiogram and the changes observed
56.
in serial studies.
Circulation
195;
9
: 860–867.
Schunkert H, Hense HW, Holmer SR,
57.
et al.
Association between a deletion
polymorphism of angiotensin converting enzyme gene and left ventricular
hypertrophy.
N Engl J Med
1994;
330
: 1634–1638.
DevereuxRB, LutesEM,CasalePN,
58.
et al
. StandardizationofM-modeechocardiographic
left ventricular anatomic measurements.
J Am Coll Cardiol
1984;
4
: 1222.
Mbanya JC, Sobngwi E, Mbanya DNS, Ngu KB. Left ventricular hypertrophy and
59.
systolic dysfunction in a diabetic population of Cameron.
Diabetes Metab
2001;
27
: 378–382.
Babalola RO, Ajayi AA. A cross sectional study of echocardiographic indices,
60.
treadmill exercise capacity and micro vascular complications in Nigerian patients
with hypertension associated diabetes mellitus.
Diabet Med
1992;
9
: 899–903.
Osuntokun BO, Akinkugbe FM, Francis TI. Diabetes mellitus in Nigeria: a study of
61.
832 patients
W Afr J Med
1971;
20
: 295–298.
Araoye MA, Omotoso ABO, Opadijo OG. The orthogonal and 12-lead ECG in
62.
adult Negroes with systemic hypertension; comparison with age-matched control.
W Afr J Med
1998;
17
: 157–164.
Huston SL, Bunker CH, Ukoli FA. Electrocardiographic LVH by five criteria among
63.
civil servants in Benin city, Nigeria, prevalence and correlates.
Int J Cardiol
1999;
70
: 1–14.
Crews DC, Plantinga LC, Miller ER,
64.
et al.
Prevalence of chronic kidney disease in
persons with undiagnosed or prehypertension in the United States.
Hypertension
2010;
55
: 1102–1109.
Mann JF, Gerstein HC, Pogue J. Renal insufficiency as a predictor of cardiovascular
65.
outcomes and the impact of ramipril: The HOPE randomised trial.
Ann Intern Med
2001;
134
: 629–636.